Arcturus Therapeutics Holdings (ARCT) Receivables (2018 - 2025)
Historic Receivables for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to $15.9 million.
- Arcturus Therapeutics Holdings' Receivables fell 7367.13% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.9 million, marking a year-over-year decrease of 7367.13%. This contributed to the annual value of $7.9 million for FY2024, which is 8760.6% down from last year.
- Per Arcturus Therapeutics Holdings' latest filing, its Receivables stood at $15.9 million for Q3 2025, which was down 7367.13% from $34.4 million recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Receivables registered a high of $185.0 million during Q1 2023, and its lowest value of $4.0 million during Q1 2021.
- For the 5-year period, Arcturus Therapeutics Holdings' Receivables averaged around $32.7 million, with its median value being $7.9 million (2024).
- Per our database at Business Quant, Arcturus Therapeutics Holdings' Receivables surged by 240563.53% in 2023 and then crashed by 8760.6% in 2024.
- Arcturus Therapeutics Holdings' Receivables (Quarter) stood at $6.7 million in 2021, then dropped by 17.91% to $5.5 million in 2022, then surged by 1060.06% to $64.1 million in 2023, then crashed by 87.61% to $7.9 million in 2024, then skyrocketed by 100.08% to $15.9 million in 2025.
- Its Receivables was $15.9 million in Q3 2025, compared to $34.4 million in Q2 2025 and $29.1 million in Q1 2025.